 |
|
Financial Indigestion
Jerome P. Kassirer, MD
Boston, Mass
JAMA. 2000;284:2156-2157.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Over the past decade, I have had the fun and good fortune of being a visiting professor at more than two dozen teaching hospitals. One noon conference during a recent visit, however, stands out.
The chief resident had asked me ahead of time to discuss financial conflict of interest, but he neglected to inform me that a major pharmaceutical company would be hosting lunch before the conference. When I arrived, one of the two well-dressed drug reps asked politely who I was, then invited me to have lunch. I demurred when I learned his company was the sponsor.
One by one, house officers and medical students arrived to join the buffet line and were greeted warmly by the drug rep with "How was your weekend?" and "How're you doing?" The line moved slowly because it took some time to scoop up the salad, the pasta, and . . . [Full Text of this Article]
RELATED ARTICLES
Policies on Faculty Conflicts of Interest at US Universities
Mildred K. Cho, Ryo Shohara, Anna Schissel, and Drummond Rennie
JAMA. 2000;284(17):2203-2208.
ABSTRACT
| FULL TEXT
Assessing Faculty Financial Relationships With Industry: A Case Study
Elizabeth A. Boyd and Lisa A. Bero
JAMA. 2000;284(17):2209-2214.
ABSTRACT
| FULL TEXT
Conflicts of Interest in Biomedical Research
David Korn
JAMA. 2000;284(17):2234-2237.
EXTRACT
| FULL TEXT
Conflict of Interest and the Public Trust
Catherine D. DeAngelis
JAMA. 2000;284(17):2237-2238.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
From "publish or perish" to "patent and prosper".
Schachman
J. Biol. Chem. 2006;281:6889-6903.
FULL TEXT
The Company We Keep: Why Physicians Should Refuse to See Pharmaceutical Representatives
Brody
Ann Fam Med 2005;3:82-85.
ABSTRACT
| FULL TEXT
Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry -- Self-Regulation in the Shadow of Federal Prosecution
Studdert et al.
NEJM 2004;351:1891-1900.
FULL TEXT
Medical Innovation and Institutional Interdependence: Rethinking University-Industry Connections
Gelijns and Thier
JAMA 2002;287:72-77.
ABSTRACT
| FULL TEXT
JAMA 2001 Medical Education Issue: A Call for Papers
Lurie
JAMA 2001;285:465-466.
FULL TEXT
Free Meals From the Pharmaceutical Industry
Echikson et al.
JAMA 2001;285:164-166.
FULL TEXT
Conflict of Interest and the Public Trust
DeAngelis
JAMA 2000;284:2237-2238.
FULL TEXT
|
